PTPRC and small cell lung carcinoma: Among the CK‐positive SCLC patients, 67% (38 out of 57) had the (CK+PD‐L1+CD45−) phenotype and the most frequent phenotype was (CK+PD‐L1−CD45−) with 72% (41 out of 57) (Fig. 1E).